Cytotoxic T lymphocytes that specifically lyse HIV-1-infected cells occur at uncommonly high frequency in the blood of infected individuals. The CTL response is dominated by the recognition of a small number of peptides encoded by HIV-1 structural and regulatory genes. These two facts have enabled us to develop potent HIV-specific CTL lines from the blood of infected patients without AIDS opportunistic infections by ex vivo culture of nonspecifically stimulated T cell lines with autologous antigen-presenting cells (APCs) preincubated with immunodominant HIV-1 peptides. After one selection, HIV-specific cytotoxicity is enhanced 1.4-to sixfold. Frequency analysis of the T cell line from 1 patient revealed that after exposure to peptide-incubated autologous B-LCLs, the frequency of CTLs specific for the gpl60-expressing APCs was enhanced 6-fold and, after a second exposure, 11-fold compared to the nonselected T cell line. Because the APCs used for the frequency analysis were EBV-transformed B-LCLs, some of the specific CTLs in the culture recognized the EBV-expressing APCs. HIV-specific cytotoxicity is enhanced without augmentation of EBV-specific cytotoxicity when PBMCs are used as APCs. Because T cell lines enhanced for HIV-1 specificity are highly cytotoxic and can be expanded to approximately 109-1010 cells/ml of blood, they may be useful for laboratory research or for immunotherapy.
INTRODUCTION
ing as targets autologous B cells incubated with overlapping peptides spanning the region identified with the vaccinia trun-HUMAN immunodeficiency viRus-specific cytotoxic T lym-cations.20 Their method can be applied to characterize the domphocytes (CTLs) are unusually abundant in the blood of inant CTL epitopes recognized by nonspecifically stimulated HIV-1-infected individuals before they develop opportunistic CTL lines from the blood of HIV-infected patients.21
infections. In fact, HIV-1 and HTLV-I are the only known hu-Immunodominant HIV-encoded CTL epitopes can also be man pathogens in which viral-specific cytolytic activity is de-mapped directly using overlapping peptides, bypassing the vactectable in freshly isolated peripheral blood mononuclear cells cinia step. 7-22-25 We have found, using nonspecifically stimu-(PBMCs) without in vitro selection.119 Most asymptomatic in-lated T cell lines generated from the PBMCs of HIV-1-seroposfected patients have CTLs that recognize HIV-1 env-, gag-, and itive subjects, that the CTL response to HIV-1 env, pol, gag, ««/-encoded proteins, but other HIV-1 genes, including pol, vif, and nefgene products is dominated by the recognition of a small rev, and tat, have also been reported to encode CTL epitopes number of virally encoded peptide epitopes.26 in some patients.3-7-9-16-17 Walker et al. mapped T cell epitopes Because of both the frequency of viral-specific CTLs in HIVrecognized by CTL clones derived from the blood of HIV-in-1 infection, which is unusually high compared with other lafected patients using autologous B cell targets in a 51Cr release tent viral infections, and the dominance of HIV-1 CTL recogassay. The targets were first infected with nested truncated vac-nition by a small number of peptide epitopes, we (Fig. 6) (Fig. 5) . Both PBMCs and B cells were able to present antigen to the extent that the peptide-specific cytotoxicity of the selected T cell lines at an E:T ratio of 3:1 was comparable to that of the unselected line at 25:1. However, the en- (Fig. 8) . During the 3-week culture, there is some selection for HIV-specific CTLs even without adding specific peptide, which may be seen by the difference in peptide-specific cytolysis in the unselected T cell line compared with the unselected PBMCs. Although the starting CTL activity is greater in the T cell line, the relative enhancement of specific lysis is comparable for the two starting populations. It is likely that sequential stimulation of PBMCs will result in at least as potent a specific CTL line, although the absolute number of cells will be reduced. [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] in the context of B8), and JL32, derived from a normal individual and specific for autologous B-LCLs, were used to determine the ED5o for CTL clones and to obtain an estimate of the absolute frequency of target-specific CTLs in the T cell lines before and after peptide selection.
bT cell clone JL32 was tested against the autologous EBV-transformed B-LCL target. Clone En 15-204 was tested against autologous B-LCLs preincubated for 2 hr with the gpl60 peptide (49) (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) , followed by washing of unbound peptide. T cell line 138 was tested for cytotoxicity against gpl60 with vPE16-infected autologous B cell targets and for cytotoxicity against EBV and vaccinia with vSC8-infected autologous targets. Part of the lysis attributed to gpl60 is actually directed against the EBV-transformed B cell line.
There were insufficient data to validate the fit by the y2 test for this cell line target pair.
DISCUSSION
In previous work we have shown that the CTL response to HIV-1 gpl60 and RT in T cell lines, generated from the peripheral blood lymphocytes (PBLs) of infected individuals by nonspecific stimulation with mitogen and IL-2, is dominated by the recognition of a small number of peptide epitopes.21 In this article we have shown that dominant HIV-1 peptides may be used to expand HIV-specific CTL ex vivo from PBMCs or T cell lines. T cell lines, whose growth has slowed from the period of initial rapid exponential growth but has not stopped, are most responsive to peptide selection (data not shown). Repeated exposure to peptide-APC is able to select in a stepwise fashion for peptide-specific CTLs, until after a few selections a significant fraction of T cells in the culture recognizes the stimulating peptide-APC. Peptide-specific cytotoxicity is enriched approximately 1.4-to sixfold by one selection, depending on the peptide and the starting cell line. The variability of enrichment for CTLs recognizing different peptides may be due to multiple factors. These might include the relative frequency or state of activation of peptide-specific CTLs in the heterogeneous cell lines, the efficiency of processing the 15-to 22-amino acid stimulating peptides into the natural 8-to 11-amino acid peptides that are presented by class I MHC molecules, the affinity of the HIV-1 peptide for MHC class I, or of the peptide-MHC complex for the TcR.
When free peptide was added to the T cell cultures without APCs, there was a relative enrichment of peptide-specific CTLs, although there was a dose-related decrease in the number of viable T cells compared with cultures to which no peptide was added. The decline in cell numbers suggests that peptide-sensitized T cells in the culture were lysed by peptide-specific CTLs. Two groups have shown that the addition of cognate peptide to CTLs results in dose-related destruction, probably by fratricide, the lysis of neighboring peptide-presenting CTLs.41^*3 The enhancement of peptide-specific cytolysis after peptide addition suggests that at least at the doses of peptides used in these experiments (1-50 pg/ml), clonal expansion predominates over peptide-induced autolysis. However, the stimulation of heterogeneous T cell lines with peptide-APC is more efficient than stimulation with peptide alone-not only is the enrichment for peptide-specific lysis somewhat enhanced but the cultures treated with peptide-APC have a substantial proliferative advantage.
HIV-specific CTL lines may be useful for adoptive immunotherapy. There is a large body of circumstantial evidence that supports the hypothesis that viral-specific CTLs are important in controlling viral replication. This evidence includes in vitro studies that demonstrate inhibition of viral replication by HIV-specific CTLs,44-45 studies in acute infection that show that the appearance of viral-specific CTLs coincides with the resolution of viremia,46 evidence that viral-specific CTLs de- 
